{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:04Z","timestamp":1790803264903,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00228-012-1260-3","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T10:07:10Z","timestamp":1332929230000},"page":"1385-1394","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension"],"prefix":"10.1007","volume":"68","author":[{"given":"William B.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Marbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Komjathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Sumeray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane R.","family":"Mould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,29]]},"reference":[{"issue":"2","key":"1260_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.pap.0000249908.55361.de","volume":"14","author":"C Feldstein","year":"2007","unstructured":"Feldstein C (2007) Management of hypertensive crises. Am J Ther 14(2):135\u2013139","journal-title":"Am J Ther"},{"issue":"5","key":"1260_CR2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/cc2351","volume":"7","author":"J Varon","year":"2003","unstructured":"Varon J, Marik PE (2003) Clinical review: the management of hypertensive crises. Crit Care 7(5):374\u2013384","journal-title":"Crit Care"},{"key":"1260_CR3","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.2146\/ajhp070105","volume":"64","author":"TW Brooks","year":"2007","unstructured":"Brooks TW, Finch CK, Lobo BL, Deaton PR, Varner CF (2007) Blood pressure management in acute hypertensive emergency. Am J Health Syst Pharm 64:2579\u20132582","journal-title":"Am J Health Syst Pharm"},{"issue":"Suppl 1","key":"1260_CR4","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1540-8191.2006.00214.x","volume":"21","author":"AT Cheung","year":"2006","unstructured":"Cheung AT (2006) Exploring an optimum intra\/postoperative management strategy for acute hypertension in the cardiac surgery patient. J Card Surg 21 [Suppl 1]:S8\u2013S14","journal-title":"J Card Surg"},{"key":"1260_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-6576.1993.tb03819.x","volume":"99","author":"JH Levy","year":"1993","unstructured":"Levy JH (1993) The ideal agent for perioperative hypertension and potential cytoprotective effects. Acta Anaesthesiol Scand Suppl 99:20\u201325","journal-title":"Acta Anaesthesiol Scand Suppl"},{"key":"1260_CR6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1213\/01.ane.0000281443.13712.b9","volume":"105","author":"JH Levy","year":"2007","unstructured":"Levy JH, Mancao MY, Gitter R, Kereiakes DJ, Grigore AM, Aronson S, Newman MF (2007) Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anaesth Analg 105:918\u2013925","journal-title":"Anaesth Analg"},{"key":"1260_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1213\/ane.0b013e3181732e53","volume":"107","author":"N Singla","year":"2008","unstructured":"Singla N, Warltier DC, Gandhi SD et al (2008) Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Anesth Analg 107:59\u201367","journal-title":"Anesth Analg"},{"issue":"3","key":"1260_CR8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1527-3466.2004.tb00143.x","volume":"22","author":"M Nordlander","year":"2004","unstructured":"Nordlander M, Sjoquist PO, Ericsson H, Ryden L (2004) Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultra short-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev 22(3):227\u2013250","journal-title":"Cardiovasc Drug Rev"},{"issue":"5","key":"1260_CR9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/00000542-200205000-00010","volume":"96","author":"JM Bailey","year":"2002","unstructured":"Bailey JM, Lu W, Levy JH, Ramsay JG, Shore-Lesserson L, Prielipp RC, Brister NW, Roach GW, Jolin-Mellgard A, Nordlander M (2002) Clevidipine in adult cardiac surgical patients: a dose-finding study. Anesthesiology 96(5):1086\u20131094","journal-title":"Anesthesiology"},{"issue":"4","key":"1260_CR10","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00000542-200004000-00016","volume":"92","author":"H Ericsson","year":"2000","unstructured":"Ericsson H, Bredberg U, Eriksson U, Jolin-Mellgard A, Nordlander M, Regardh CG (2000) Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology 92(4):993\u20131001","journal-title":"Anesthesiology"},{"key":"1260_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/009286159202600108","volume":"26","author":"C Chuang-Stein","year":"1992","unstructured":"Chuang-Stein C (1992) Summarizing laboratory data with different reference ranges in multi-center clinical trials. Drug Inf J 26:77\u201384","journal-title":"Drug Inf J"},{"key":"1260_CR12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/009286150103500117","volume":"35","author":"C Chuang-Stein","year":"2001","unstructured":"Chuang-Stein C (2001) Some issues concerning the normalization of laboratory data based on reference ranges. Drug Inf J 35:153\u2013156","journal-title":"Drug Inf J"},{"key":"1260_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/009286150303700112","volume":"37","author":"J Karvanen","year":"2003","unstructured":"Karvanen J (2003) The statistical basis of laboratory data normalization. Drug Inf J 37:101\u2013107","journal-title":"Drug Inf J"},{"issue":"5","key":"1260_CR14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2125.1999.00933.x","volume":"47","author":"H Ericsson","year":"1999","unstructured":"Ericsson H, Fakt C, Jolin-Mellgard A, Nordlander M, Sohtell L, Sunzel M, Regardh CG (1999) Clinical and pharmacokinetic results with a new ultra short-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Br J Clin Pharmacol 47(5):531\u2013538","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1260_CR15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00005344-199908000-00013","volume":"34","author":"JH Schwieler","year":"1999","unstructured":"Schwieler JH, Ericsson H, Lofdahl P, Thulin T, Kahan T (1999) Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans. J Cardiovasc Pharmacol 34(2):268\u2013274","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"1260_CR16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002280050594","volume":"55","author":"H Ericsson","year":"1999","unstructured":"Ericsson H, Fakt C, Hoglund L, Jolin-Mellgard A, Nordlander M, Sunzel M, Regardh CG (1999) Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. Eur J Clin Pharmacol 55(1):61\u201367","journal-title":"Eur J Clin Pharmacol"},{"key":"1260_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0928-0987(98)00058-X","volume":"8","author":"H Ericsson","year":"1999","unstructured":"Ericsson H, Tholander B, Reg\u00e5rdh CG (1999) In vitro hydrolysis rate and protein binding of clevidipine, a new ultra short-acting calcium antagonist metabolized by esterases, in different animal species and man. Eur J Pharm Sci 8:29\u201337","journal-title":"Eur J Pharm Sci"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00228-012-1260-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T16:13:59Z","timestamp":1497975239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-012-1260-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,29]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1260"],"URL":"https:\/\/doi.org\/10.1007\/s00228-012-1260-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,29]]}}}